APRO 88 Catheter
Catheter, Percutaneous, Neurovasculature. 510(k) K261938, from Alembic, LLC (Mountain View, CA). Product code QJP, class 2.
As of Nov 18, 2026, K261938 is an FDA 510(k) held by Alembic, LLC, substantially equivalent on Oct 6, 2026 after 118 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Oct 6, 2026
- Review time: 118 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe APRO 88 Catheter is indicated for use in facilitating the insertion and guidance of appropriately sized interventional devices into a selected blood vessel in the peripheral and neurovascular systems. 6)
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- APRO 70 Swift CatheterK243297 · Alembic, LLC · Jan 14, 2025
Other QJP Clearances
The newest 510(k)s for the same product code; their median review was 216 days; see every QJP device- Excelsior Reach MicrocatheterK261649 · Stryker Neurovascular · Oct 9, 2026
- OAB Delivery CatheterK253422 · Cognition Medical Corp. · Oct 2, 2026
- Route 92 Medical Full Length 046 Access SystemK260220 · Route 92 Medical, Inc. · Sep 16, 2026
- 70 NeuGlide CatheterK262277 · Piraeus Medical, Inc. · Sep 4, 2026
- Zoom 4S CatheterK261176 · Imperative Care, Inc. · Aug 28, 2026
- p17 XR MicrocatheterK254071 · Wallaby Medical · Aug 18, 2026
- SLIM MicrocatheterK260199 · Balt USA, LLC · Jul 13, 2026
- Millipede88 Access CatheterK253901 · Perfuze, Ltd. · Jul 9, 2026
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 10, 2026
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files